The GenetiSure Cyto microarrays feature updated and clinically relevant content from respected databases, according to the firm. In addition, the microarray probes yield high-resolution detection of copy number variations and copy-neutral loss of heterozygosity associated with developmental delays, neuropsychiatric disorders, intellectual disability, congenital anomalies, or unexplained dysmorphic features in constitutional DNA samples, Agilant said.

What's more, the new arrays utilize different specifications -- depending on if they are being used for pre- or postnatal research -- to focus on clinically relevant regions. The arrays can achieve up to exon-level resolution, according to the firm.